TOP TIERMARKET NEWSWIRE
News & sentiment

INHIBITOR THERAPEUTI (INTI) — News & AI sentiment

INHIBITOR THERAPEUTI (INTI) news roundup. 6 stories in the past week, 10 over 30 days. Average 30-day sentiment is 58.4/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
6
avg sentiment 58.7/100
30d stories
10
avg sentiment 58.4/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

INTI news in the last 24 hours, 7 days, 30 days and 90 days

How much INTI coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowINTI storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days658.7/100INTI headlines →
Last 30 days1058.4/100INTI headlines →
Last 90 days1861.8/100INTI headlines →

Latest stories on INTI

5d ago
5d ago
5d ago
5d ago
5d ago
5d ago
Sep 3
Aug 26
Aug 19
Aug 19
Aug 6
Jul 23
Curis Announces Positive Emavusertib Update
StockTitan67 · bullishproduct/pr
Jul 22
Jul 17
Jul 13
Jul 9
Jul 9
Jun 16
Jun 10
May 19
May 19
Open INTI in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →